Indefinite Delivery Contract 75A50122D00021
Award Date
9/30/22
Last Date to Order
9/29/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Cost Plus Fixed Fee
Legislative Mandate
Clinger Cohen Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a single-award, indefinite delivery/indefinite quantity contract valued up to $100 million to Lovelace Biomedical Research Institute. Under this contract, Lovelace will establish and utilize animal models to support the development of medical countermeasures against radiological and nuclear threats. A $1.986 million cost-plus-fixed-fee delivery order was issued to Lovelace for...
The Department of Health and Human Services (HHS) awarded an indefinite delivery/indefinite quantity (IDIQ) contract to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization, to provide nonclinical laboratory services for the development and testing of medical countermeasures against chemical threats. The $45 million, single-award IDIQ contract has a period of performance through July 2025. The contract scope covers two groups of services: Group A...
The Lovelace Biomedical Research Institute has been awarded an indefinite delivery contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. With a potential value of $150 million, this single award IDV enables NIAID to procure preclinical product development services for candidate products from Lovelace through July 2023. Under the IDV, Lovelace has received a $486,301 cost-plus-fixed-fee delivery order to transfer, validate and qualify bioanalytical...
This indefinite delivery contract (IDC) was awarded by the Defense Health Agency (DHA), a defense agency, to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $2,500.00 firm-fixed-price delivery order is for military medical research and development services, with no set-aside designation. Lovelace Biomedical Research Institute provides pharmaceutical and biotechnology partners with a range of preclinical research services across the drug...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Lovelace Biomedical Research Institute on September 1, 2021 with a potential value of $545,452,906. Under the terms of the contract, Lovelace Biomedical Research Institute will provide a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies, analytics,...
The Federal Supply Schedule contract GS07F6002R was awarded to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute, a not-for-profit contract research organization. This multiple award IDV provides a range of preclinical research services to federal agencies such as the NIH, NIAID, NCATS, BARDA, and Leidos. Through task orders under this contract, LBERI performs activities like efficacy testing of HIV therapeutics,...
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a single award indefinite delivery contract to Southern Research Institute located in Birmingham, Alabama. With a potential value of $100 million and a period of performance through September 2027, this contract aims to procure biological animal model and medical countermeasure development services in support of the Biomedical Advanced Research and Development Authority. A $4.68...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a single-award, indefinite delivery contract to the Texas Biomedical Research Institute, doing business as the Southwest Foundation for Biomedical Research. The contract has a potential value of $100 million and a period of performance through September 2027 to provide biological animal model and medical countermeasure development support. Two associated delivery orders have been...
This indefinite delivery contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Lovelace Biomedical Research Institute, a not-for-profit contract research organization based in Albuquerque, New Mexico. The $17.89 million multiple-award contract, which runs through April 2025, is for contract research organization (CRO) support for NCATS' medicinal chemistry work focused on lead optimization. Under the...
The federal contract IDV award provides indefinite delivery of nonclinical biological services to the Department of Health and Human Services (HHS), specifically the Office of the Assistant Secretary for Preparedness and Response (ASPR). The purpose is to establish a network of Good Laboratory Practices (GLP) facilities capable of conducting animal testing and other analytical services to support the development of medical countermeasures against chemical, biological, radiological, and nuclear...